Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar;8(1):58-65.
doi: 10.1007/s11481-012-9420-x. Epub 2012 Nov 18.

MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase

Affiliations

MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase

John H Anneken et al. J Neuroimmune Pharmacol. 2013 Mar.

Abstract

3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy) is a popular drug of abuse with well-documented acute effects on serotonergic, dopaminergic, and cholinergic transmitter systems, as well as evidence of long-term disruption of serotoninergic systems in the rat brain. Recently, it was demonstrated that MDMA evokes a delayed and sustained increase in glutamate release in the hippocampus. The purpose of the present study was to determine the role of inflammatory mediators in the MDMA-induced increase in glutamate release, as well as the contribution of inflammatory pathways in the persistent neurochemical toxicity associated with repeated MDMA treatment. Treatment with the non-selective cyclooxygenase (COX) inhibitor ketoprofen and the COX-2 selective inhibitor nimesulide attenuated the increase in extracellular glutamate in the hippocampus evoked by repeated MDMA exposure (10 mg/kg, i.p., every 2 h); no attenuation was observed in rats treated with the COX-1 selective inhibitor piroxicam. Reverse dialysis of a major product of COX activity, prostaglandin E2, also resulted in a significant increase in extracellular glutamate in the hippocampus . Repeated exposure to MDMA diminished the number of parvalbumin-positive GABA interneurons in the dentate gyrus of the hippocampus, an effect that was attenuated by ketoprofen treatment. However, COX inhibition with ketoprofen did not prevent the long-term depletion of 5-HT in the hippocampus evoked by MDMA treatment. These data are supportive of the view that cyclooxygenase activity contributes to the mechanism underlying both the increased release of glutamate and decreased number of GABA interneurons in the rat hippocampus produced by repeated MDMA exposure.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Effect of the COX 1/2 inhibitor ketoprofen. COX-1 inhibitor piroxicam, and COX-2 inhibitor nimesulide on the MDMA-induced efflux of glutamate in the rat hippocampus
Rats received ketoprofen (5 mg/kg, s.c.), piroxicam (3 mg/kg, i.p.) (inset), nimesulide (7.5 mg/kg, i.p.) (inset) or vehicle 1 h prior to and 1 h and 3 h following the first injection of MDMA (10 mg/kg, i.p.) or vehicle. (n= 4-14 per group). Average basal glutamate for VEH-MDMA group was 2.54 ± 0.34 ng/20μL (uncorrected for recovery). Arrows indicate injections with MDMA or Veh. * Indicates values that differ significantly (p
Figure 2
Figure 2. Extracellular glutamate concentrations in the hippocampus following reverse dialysis of PGE2
PGE2 (30μM) or vehicle was infused via the dialysis buffer into the hippocampus for a duration of 90 min after three 30 min baseline samples were taken. The concentration of PGE2 was then increased to 100μM for an additional 90 min. (n=5-8 per group) *Indicates values that differ significantly (p<0.05) from those animals that received vehicle.
Figure 3
Figure 3. Effect of ketoprofen on the MDMA-induced reduction of parvalbumin-reactive GABAergic neurons in the rat hippocampus
Panel A is a representative photomicrograph depicting parvalbumin-immunoreactive cells in the dentate gyrus in control animals, as highlighted by the arrows, while panel B is representative of the dentate gyrus of animals given repeated doses of MDMA. Panel C depicts the quantitative assessment of PV-ir neurons in the dentate gyrus of vehicle- and MDMA-treated rats. Rats received ketoprofen (5 mg/kg, s.c.) or vehicle 1 h prior to and 1 h and 3 h following the first of 4 injections of MDMA (10 mg/kg, i.p.) or vehicle. (n = 4-8 per group) * indicates values that differ significantly (p

Similar articles

Cited by

References

    1. Able JA, Gudelsky GA, Vorhees CV, Williams MT. 3,4-methylenedioxymethamphetamine in adult rats produces deficits in path integration and spatial reference memory. Biol Psychiatry. 2006;59:1219–1226. - PMC - PubMed
    1. Anneken JH, Gudelsky GA. MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus. Neuropharmacology. 2012 - PMC - PubMed
    1. Armstrong BD, Noguchi KK. The neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine on serotonin, dopamine, and GABA-ergic terminals: An in-vitro autoradiographic study in rats. Neurotoxicology. 2004;25:905–914. - PubMed
    1. Asanuma M, Tsuji T, Miyazaki I, Miyoshi K, Ogawa N. Methamphetamine-induced neurotoxicity in mouse brain is attenuated by ketoprofen, a non-steroidal anti-inflammatory drug. Neurosci Lett. 2003;352:13–16. - PubMed
    1. Asi SS, Farhadi HM, Mousavizadeh K, Samadikuchaksaraei A, Soleimani M, Jameie SB, Joghataei MT, Samzadeh-Kermani A, Hashemi-Nasl H, Mehdizadeh M. Evaluation of Bcl-2 Family Gene Expression in Hippocampus of 3,4-methylenedioxymethamphetamine Treated Rats. Cell Journal. 2012 2012 Winter13(4) - PMC - PubMed

Publication types

MeSH terms